Espada, Luis C.
HRN: 22-75-62 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/19/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/19/2023
03/25/2023
IV
2.25 Grams
Q 6 Hrs
Cap
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: No Wrong Dose Wrong Dose
Overall appropriateness: No Wrong Dose